본문바로가기

News & Events

  • EventEANM 2023

    Venue: Austria Center Vienna (ACV), Vienna, AustriaDate:  Sep 09-13, 2023We cordinally invite you to visit us at booth #409.Meet Brightonix Imaging team and talk with us.

  • NewsBrightonix Imaging receives Excellence Award on Pitching & Connect Day held by Seoul Start-up Hub Scale-up Center

    Brightonix Imaging receives Excellence Award on Pitching & Connect Day held by Seoul Start-up Hub Scale-up Center Brightonix Imaging Inc. (led by Jae Sung Lee, CEO), a deep-tech medical imaging specialist, was awarded the Excellence Award at the Seoul Startup Hub Scale-up Pitching & Connect Day event organized by the Seoul Business Agency (SBA) and Hana Ventures.  The event took place on July 6th at the eoul Startup Hub Scale-up Center, located in the Korea Science and Technology Center in Gangnam-gu, Seoul. Among the 140 companies that Hana Ventures has invested in over the past five years, eight outstanding portfolio companies were pre-selected through screening to participate in the IR pitching session. Among them, four outstanding companies were selected and awarded.  Brightonix Imaging was recognized for commercializing positron emission tomography (PET) for the first time in Korea, starting with the supply to the U.S. National Institutes of Health (NIH) and generating overseas exports, and for the excellent performance of the Pharos PET system, which is being developed to respond to the demand for PET testing for Alzheimer's disease, which is expected to increase rapidly in the future.In addition, BTXBrain, an artificial intelligence (AI)-based brain PET/SPECT image analysis software that secured an unparalleled sales advantage within six months of domestic medical device approval, was also recognized for supplying it to leading medical institutions such as Seoul National University Hospital and Seoul St. Mary's Hospital in collaboration with GE and Siemens. "By next year, we will complete the licensing of the Pharos PET system and BTXBrain medical devices in Korea, the U.S., and Europe," said Jae Sung Lee, CEO of Brightonix Imaging. "Brightonix Imaging will show that Korea's advanced medical device technology can work in the ultra-high-end medical imaging market." <저작권자 ⓒ 약품신문 무단전재 및 재배포 금지>출처: 브라이토닉스이미징, 서울창업허브 스케일업 피칭&커넥트데이 우수상 수상-약품신문 - http://www.yakpum.co.kr/6703

  • NewsAdvanced brain imaging technology of Brightonix Imaging gains a focus at SNMMI 2023 meeting

    Advanced brain imaging technology of Brightonix Imaging gains a focus at SNMMI 2023 meetingBrightonix Imaging (led by Jae Sung Lee, CEO) showcased advanced brain imaging technology and its related products at the Society of Nuclear Medicine and Molecular Imaging (SNMMI) conference held at McCormick Place in Chicago, USA, from June 24th for four days. This SNMMI conference, the first to be held in the US since the onset of the COVID-19 pandemic, had approximately 8,000 oneline and offline attendees who are nuclear medicine and molecular imaging experts and industry professionals. With the support of the Korea Medical Device Development Fund, the Pharos PET system, which is currently under clearance of domestic and international medical device approvals, and BTXBrain, which gained domestic medical device approval at the end of last year and has established a dominant market position in the field of AI-based brain PET image analysis software, drew significant attention from SNMMI participants from various countries. This can be interpreted as a response to the recent FDA approval of Biogen's Leqanemab (Leqambi), a novel anti-amyloid therapy for Alzheimer's disease, and the successful outcome of Eli Lilly's phase III clinical trial of Donanemab, leading to a significant expansion of amyloid brain PET tests. It is also related to the increasing demand for PET exams due to the rise in radiotherapy for prostate cancer and neuroendocrine tumors, leading to an increase in waiting times for the exams. Furthermore, Guenbae Ko, Director of Brightonix Imaging's Research Institute, presented the evaluation results of the Pharos PET system's performance at oral presentations. This presentation once again drew attention as an innovative technology, highlighted by Professor LJ Meng of the University of Illinois during the summary session in the fields of physics, equipment, and data science. Brightonix Imaging's Pharos PET system, which won the 2022 Innovation Start-up Award granted by the Ministry of Science and ICT, was also selected as one of the top 10 representative achievements of the Korea Medical Device Development Fund Projects in May.Brightonix Imaging will continue its promotion by having exhibit booths at the Alzheimer's Association International Conference (AAIC 2023) in Amsterdam, Netherlands, from July 16th, and at the European Association of Nuclear Medicine (EANM 2023) in Vienna, Austria, from September 9th. Copyrightⓒ사이언스엠디뉴스 무단 전재 및 재배포 금지

  • NewsTop 10 promosing technologies leading the medical device industry: Patient-specific dental model, Brain PET, Peripheral microvascular disgnostic d...

    Top 10 promosing technologies leading the medical device industry: Patient-specific dental model, Brain PET, Peripheral microvascular disgnostic device... Leading South Korea to a stronghold of medical devicesThe government has announced the top 10 key technologies aimed at propelling South Korea to become the 5th largest exporter of medical devices, with an estimated medical device export value of approximately 21 trillion won by 2027. The selection includes groundbreaking medical devices that are expected to be developed for the first time globally, as well as initiatives focused on domesticating imported medical devices, addressing public health and social issues. The government plans to continuously foster future growth opportunities by unveiling 10 representative projects each year.On the 23rd, the Medical Device Research and Development Project Group held the "2023 Performance Report Conference" at The Westin Chosun Seoul hotel, where they announced the top 10 representative projects. This performance report conference, which was jointly sponsored by the Ministry of Science and ICT, the Ministry of Trade, Industry and Energy, the Ministry of Health and Welfare, and the Ministry of Food and Drug Safety, marked its first occurrence since the establishment of the task force.Kim Beob-min, the head of the task force, explained, "Since its establishment, we have built a support system as a platform to enhance the success rate of medical device research and development (R&D) and generate excellent results by providing support for various research projects. We will actively communicate with researchers and promote the commercialization of medical devices." He added, "The leading projects selected each year may involve technologies that have been previously selected, as well as new technologies."The selected representative projects are expected to play a pivotal role in achieving the government's goal of becoming the 5th largest exporter of medical devices, which was set by Yoon Seok Yeol government. In February of this year, the government announced plans to expand the medical device export value from approximately 8.6 billion dollars in 2021 to 16 billion dollars by 2027, positioning South Korea as a leading exporter in the field.The 10 projects announced include promising fields such as medical imaging diagnosis, in vitro diagnostics, dental technology, and digital health. Among them, three projects are anticipated to win the world's first title. Director Kim stated, "We selected these projects based on evaluations considering the appropriateness of research and development execution, technological and medical aspects, as well as the socio-economic ripple effects, out of a total of 869 achievements submitted by 90 organizations."The followings are the top 10 medical device projects, the institutions involved, and their development status that have been underway since 2020. [omitted]Development of Brain PET System and Integrated Molecular Imaging Platform to Overcome Neurodegenerative Brain DiseasesBrightonix Imaging aims to domestically produce medical device by developing brain PET system targeting neurodegenerative diseases such as dementia and Parkinson's disease. Currently, for the diagnosis of neurodegenerative diseases in the elderly, the combination of computed tomograhy (CT) or magnetic resonance imaging (MRI) is essential. However, this technology visualizes functional changes in the brain using PET only for disease diagnosis. Brightonix Imaging received the Korean Innovation Sartup Award by the Minister of Science and ICT. The project runs from September 1, 2020, to December 31, 2025, with government funding of 11.66 billion won. [Omitted] <Copyright holder ⓒ Prohibition of unauthorized reproduction and redistribution of Chosun Biz Newspapers>Source: 환자 맞춤형 치과모델·뇌전용PET·말초 미세혈관 진단기기...의료기기 강국 이끌 10대 유망 기술 - 조선비즈 (chosun.com)

  • NewsBrightonix Imaging selected for Post-TIPS, propelling its leap towards becoming a global unicorn company

    Brightonix Imaging selected for Post-TIPS, propelling its leap towards becoming a global unicorn companyBrightonix Imaging (led by Jae Sung Lee, CEO), a medical imaging solution company, announced that it has been selected for the "Post-TIPS" project organized by the Ministry of SMEs and Startups. Post-TIPS is a program that selects and supports promising startup companies verified through TIPS, with a focus on facilitating their substantial scale-up and fostering global unicorn companies.Through this program, Brightonix Imaging will receive funding of 500 million won for 18 months to enhance its business operations, and will have support for open innovation, scale-up, and global expansion through the Korea Institute of Science Technology (KIST), the organizing institute for Post-TIPS. Since its selection in the TIPS program in 2018, Brightonix Imaging has advanced its preclinical PET system technology and has been developing a high-resolution PET system for brain through the Korea Medical Device Development Fund in 2020. Furthermore, their AI-based brain PET image analysis solution, BTXBrain, has received approval from the Ministry of Food and Drug Safety as a medical device in December 2022 and is being rapidly deployed in domestic medical institutions.Brightonix Imaging, which leads technological innovation in the field of advanced medical imaging has also received the 2022 Korea Innovative Startup Award (Minister of Science and ICT Award), and plans to accelerate global expansion through product certifications and marketing. With the selection for the Post-TIPS program, Brightonix Imaging has gained an opportunity to leap forward as a growing company in the global market.  <Copyright holder ⓒ Prohibition of unauthorized reproduction and redistribution of Yakpum Newspapers>Source: 브라이토닉스이미징, 포스트팁스 선정… 글로벌 유니콘기업으로 도약한다-약품신문 - http://www.yakpum.co.kr/5491

  • NewsBrightonix Imaging received the Innovation Start-up Korea Award granted by the Minister of Science and ICT

    Six start-ups win Innovation Start-up Korea AwardsThe JoongAng Ilbo, KAIST and Seoul National University (SNU) hosted the annual International Symposium on 'Korea, the Country of Innovation and Start-ups' on Tuesday at SNU's campus in southern Seoul. From left: KAIST President Lee Kwang-hyung, Science Minister Lee Jong-ho, JoongAng Holdings Chairman Hong Seok-hyun and SNU President Oh Se-Jung. [KIM SANG-SEON] The JoongAng Ilbo, KAIST and Seoul National University (SNU) jointly launched an annual conference to instill entrepreneurship into Korea's business scene and recognize young tech firms with high growth potential.   In the first International Symposium on 'Korea, the Country of Innovation and Start-ups' Tuesday, six Korean start-ups won awards for their innovative approach towards business. The three sponsors plan to host the symposium every year at the end of the year, based on an agreement signed in October.The Tuesday event brought together entrepreneurship specialists, including Ami Appelbaum, chairman of the Israel Innovation Authority, and Scott Stern, professor at the MIT Sloan School of Management. Also present were JoongAng Holdings Chairman Hong Seok-hyun, Science Minister Lee Jong-ho, KAIST President Lee Kwang-hyung and SNU President Oh Se-Jung.   Bio start-ups Tomocube and Brightonix Imaging won the Innovation Start-up Korea Award granted by the science minister.   Tomocube develops high-performance laboratory microscopes using a technique called holotomography, while Brightonix Imaging has an expertise on medical imaging analysis.   Quantum Cat, a Daejeon-based firm specializing in the use of gold as a catalyst, won the award given by the SNU president.   FriendliAI, a start-up offering services that facilitate artificial intelligence analytics, grabbed the award granted by the president of KAIST. The Innovation Start-up Korea Award given by the JoongAng Holdings chairman went to Recense Medical, which makes medical devices designed for cooling cells. Pinotbio, a provider of anticancer drug technology, took home the award given by the head of National Research Council on Science & Technology.   In a welcome speech, Chairman Hong shared a story of former Israel President Shimon Peres, who is credited with propelling Israel into a hub for innovation and high-tech start-ups.   “Nestled in the southern part of Tel Aviv, a building with floor-to-ceiling windows – Peres Center for Peace and Innovation – stood near the Mediterranean Sea. The center features how Israel transformed into the home to innovative start-ups,” Hong said.   “As a country with 9 million people, Israel is battered by conflicts with neighboring Islamic countries, and poor in resources, with half of the land in the state of desert,” Hong said, “The only resource was the people, which became the basis of the miracle,” he said.   The chairman went on to stress the importance of efficiently turning breakthrough ideas into viable business opportunities.   “The problem is the so-called R&D paradox,” Hong said, “Many stellar research feats failed to grow into new growth engines."   To resolve the problem, Korea needs to embrace the spirit of the first mover, according to the KAIST President Lee.   “Korea should go beyond following other advanced countries,” Lee said, “We need a transformation to become a leading nation through research and development and the building of innovative companies.” Science Minister Lee vowed to provide more support for nurturing high-tech start-ups.   “We will foster a deeper tie between public research institutions and private institutions and amend regulations standing in the way of entrepreneurs’ efforts to run their businesses,” he said.BY PARK EUN-JEE [park.eunjee@joongang.co.kr]Six start-ups win Innovation Start-up Korea Awards (joins.com)

1 2 3
TOP